Literature DB >> 1718473

Backbone cyclization: A new method for conferring conformational constraint on peptides.

C Gilon1, D Halle, M Chorev, Z Selinger, G Byk.   

Abstract

This article describes a new concept of medium- and long-range cyclization of peptides through "backbone cyclization." In this approach, conformational constraints are conferred on a peptide by linking omega-substituted alkylidene chains replacing N(alpha) or C(alpha) hydrogens in a peptidic backbone. Backbone cyclization, which is divided into N-backbone and C-backbone cyclizations, allow for new modes of cyclization in addition to the classical ones that are limited to cyclization through the side chains and/or the amino or carboxyl terminal groups. The article also describes the application of the N-backbone cyclization to the active region of substance P. Conformational constraints of this peptide by the classical cyclization modes led to inactive analogues whereas N-backbone cyclization provided an active, selective, and metabolically stable analogue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718473     DOI: 10.1002/bip.360310619

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  28 in total

1.  On-resin peptide macrocyclization using thiol-ene click chemistry.

Authors:  Alex A Aimetti; Richard K Shoemaker; Chien-Chi Lin; Kristi S Anseth
Journal:  Chem Commun (Camb)       Date:  2010-04-08       Impact factor: 6.222

2.  β-Strand mimics based on tetrahydropyridazinedione (tpd) peptide stitching.

Authors:  Chang Won Kang; Matthew P Sarnowski; Sujeewa Ranatunga; Lukasz Wojtas; Rainer S Metcalf; Wayne C Guida; Juan R Del Valle
Journal:  Chem Commun (Camb)       Date:  2015-11-21       Impact factor: 6.222

Review 3.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

4.  Putative structural rearrangements associated with the interaction of macrocyclic inhibitors with norovirus 3CL protease.

Authors:  Anushka C Galasiti Kankanamalage; Pathum M Weerawarna; Athri D Rathnayake; Yunjeong Kim; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Kyeong-Ok Chang; William C Groutas
Journal:  Proteins       Date:  2019-04-01

Review 5.  Impact of physiochemical properties on pharmacokinetics of protein therapeutics.

Authors:  Rajan Swami; Aliasgar Shahiwala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-14       Impact factor: 2.441

Review 6.  Peptide-based imaging agents for cancer detection.

Authors:  Xiaolian Sun; Yesen Li; Ting Liu; Zijing Li; Xianzhong Zhang; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2016-06-18       Impact factor: 15.470

Review 7.  Peptidomimetic therapeutics: scientific approaches and opportunities.

Authors:  Nir Qvit; Samuel J S Rubin; Travis J Urban; Daria Mochly-Rosen; Eric R Gross
Journal:  Drug Discov Today       Date:  2016-11-14       Impact factor: 7.851

8.  Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads.

Authors:  Shirly Naveh; Yftah Tal-Gan; Song Ling; Amnon Hoffman; Joseph Holoshitz; Chaim Gilon
Journal:  Bioorg Med Chem Lett       Date:  2011-11-04       Impact factor: 2.823

9.  Designing amino acids to determine the local conformations of peptides.

Authors:  A W Burgess
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  Translation of DNA into a library of 13,000 synthetic small-molecule macrocycles suitable for in vitro selection.

Authors:  Brian N Tse; Thomas M Snyder; Yinghua Shen; David R Liu
Journal:  J Am Chem Soc       Date:  2008-10-29       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.